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1. Introduction 
Plasma alphaa -SH glycoprotein was first obtained 
and named alphas -Z by Heremans [ 1 ] . This protein 
was soluble together with IgA globulin at concentra- 
tions of zinc ions higher than 0.05 M. In 1961, 
Schmid and Biirgi [2] showed that the former, as 
well as another glycoprotein named alpha2 -Zn [3] , 
exhibited minimum solubility between 0.01 M and 
0.03 M zinc acetate in the ethanol procedure. These 
two proteins were separated to a great extent by 
using low concentration of Ba2+ ions [2] . Schultze 
et al. [4] demonstrated that the protein obtained by 
Heremans [l] and the one discovered and named 
alpha2-Ba by Schmid and Biirgi [2] were identical, 
and this protein was finally called alpha2 SH. 
Recently, Porath et al. [5] showed that chelate- 
forming ligands for metal ions (Cu, Zn, Cd, Hg, Co, 
Ni) could be attached to agarose derivatives. These 
authors demonstrated that the affinity of proteins 
for such adsorbents is pH dependent. 
As little is known about the structure of alpha2 SH, 
metal chelate affinity chromatography was used to 
obtain a better resolution of the human plasma alpha2 
globulin fraction. The present paper shows that, by 
this technique, alpha2 -SH was obtained free from 
alpha2 -Zn with a similar pI and molecular weight. 
2. Materials and methods 
CM-Sepharose CL-6B, Sephadex G-200 and 
epoxy-activated Sepharose 6B were purchased from 
Pharmacia Fine Chemicals Co., Uppsala, Sweden. 
North-Holland Publishing Company - Amsterdam 
Immunoelectrophoresis and double immunodiffusion 
were performed on 1.3% agar in 0.05 M barbital 
buffer, pH 8.2, by using antibody to human serum 
(Organon Teknika S.A.) and anti-alpha2 monospecific 
immune sera (Behringwerke A. G., Marburg, FRG). 
The alpha2 -SH content was measured by single 
radial diffusion (Partigen plate, Behringwerke A.G.). 
Protein determinations were performed by the 
Biuret method. SDS-Polyacrylamide gel electro- 
phoresis was carried out in 10% or 7.5% acrylamide. 
Gel-filtration (Sephadex G-200 column (2.5 X 100 
cm)) was carried out with 0.1 M. Tris-HCl buffer, 
pH 8.0, containing 0.1 M NaCl. The column was 
standardized with blue dextran 2000 (Pharmacia Fine 
Chemicals Co.). Fractions of 5 ml were collected. 
A human serum alpha2 globulin fraction rich in 
alpha2 SH, obtained from pooled normal human sera, 
was prepared by precipitation at 1.8 M (NH4)2S04, 
followed by ion-exchange chromatography on a 
CM-Sepharose CL-6B column equilibrated with a 
0.025 M acetate buffer, pH 5.0, containing 2 mM 
CaC12, 2 mM MgC12, 2 mM MnC12 and 50 mM 
e-aminocaproic acid. The proteins were eluted with 
the same buffer and then step-wise with increasing 
concentrations of 0.02-0.2 M NaCl. Alpha2 -SH was 
present in the first fractions eluted (up to 0.06 M 
NaCl). All the protein fractions which contained 
alpha?-SH and alpha2-Zn were pooled and two prepa- 
rations were retained for the zinc-chelate affinity 
chromatography: the first one contained apparently 
intact alpha2-SH as shown by immunoelectrophoresis 
and immunodiffusion in comparison to fresh human 
serum against a monospecific anti-alpha2-SH; the 
second one showed apparently intact alpha,-SH 
351 
Volume 80, number 2 FEBS LETTERS August 1917 
together with a spontaneous fragment of this protein, 
as shown by immunodiffusion and by immunoelectro- 
phoresis. 
Preparation of the chelate gel was carried out 
essentially as described by Porath et al. [5]: 30 ml of 
swollen epoxy-activated Sepharose 6B (bis-oxirane 
activated agarose containing approx. 1 S-20 pmol 
epoxy-groups/ml) were added to 20 ml 2 M Na2C0s 
containing 4 g iminodiacetic acid, disodium salt. The 
gel suspension was heated to 65°C and continuously 
stirred for 24 h in a water-bath. After coupling, at 
pH 12.4, the gel was thoroughly washed with distilled 
water. A water solution of ZnClz (1 g.l -’ ) was passed 
through a column containing the bis-carboxymethyl- 
amino-Sepharose 6B: 1.5 X 12 cm (1.5 ml) gel bed, 
flow rate 40 ml/h. Fractions of 2 ml were collected. 
The pH was determined in each tube and the presence 
of Zn2+ was assessed by the formation of an insoluble 
ZnCOs precipitate (0.2 ml 2 M Na2C0s). 
*L6Llnm 
0.50 
3. Results and discussion 
The gel-bound chelate of zinc was obtained by 
passing a ZnCl, solution through bis-carboxymethyl- 
amino-Sepharose 6B. In a typical experiment, the 
formation of the metal chelate was shown by a pH 
drop (pH 2.4) which remained constant from 42-85 
ml elution vol. Furthermore, Zn2+ appeared at the 
same time as the pH dropped. When the pH returned 
to neutrality, the column was equilibrated with 
0.05 M Tris-HCl buffer, pH 8.0, containing 0.15 M 
NaCl, an alpha2 fraction (26 mg in 2 ml) rich in 
apparently intact alpha2 -SH applied (see fig.1) and 
eluted with the same buffer. When the A280n,,, was 
less than 0.02, elution was continued with 0.1 M Na 
phosphate buffer, pH 6.5, containing 0.8 M NaCl. In 
the same way, 0.1 M Na acetate buffer, pH 4.5, con- 
taining 0.8 M NaCl was passed through the column 
but no appreciable absorbance was noticed. Finally, 
_F _--__ -_o 
\ 
20 40 60 60 100 120 
ELUTION VOLUME ml 
PH 
6.0 
7.0 
6.0 
6.0 
Fig.1. Zinc chelate affinity chromatography (ZCAC) of a human serum alpha, globulin fraction rich in alpha,-SH. Conditions 
were: 1.5 x 12 cm (15 ml) gel bed, sample vol. 2 ml (26 mg alpha, fraction). Elution system: (I) 0.05 M Tris-HCl buffer, 
pH 8.0, containing 0.15 M NaCl; (II) 0.1 M Na phosphate buffer, pH 6.5, containing 0.8 M NaCl; (III) 0.1 M acetate Na buffer, 
pH 4.5, containing 0.8 M NaCl, flow rate 20 ml/h. 
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Fig.2 (a) 
Fig.2(a). Immunoelectrophoretic patterns of the proteins 
eluted after zinc-chelate affinity chromatography (ZCAC: 
see fig.1). In 1: upper well, peak I; lower well, peak II 
(developed with anti-alpha, -Zn immuneserum). In 2: upper 
well, peak I; lower well, peak II (developed with anti-human 
total immuneserum). In 3: upper well, peak I; lower well, 
peak II (developed with anti-alpha,-SH immuneserum). 
Fig2(b). Controls after ZCAC (second experiment: same 
elution profile as that in fig.1; see text for details). 1,2,3: 
same disposition as that in fig.2a. In 45: controls after 
Sephadex G-200 gel filtration of peak II of ZCAC. In 4: 
upper well, first protein fraction eluting in the void volume 
of the G-200 column; lower well, second protein fraction, 
(developed with anti-human immuneserum). In 5 : same 
disposition that in 4 (developed with anti-alpha, -SH immune- 
serum). Anode is at the left. 
the column was eluted with 0.05 M EDTA, pH 7.0, 
0.5 M in NaCl, then washed with distilled water. The 
zinc chelate was regenerated by passing zinc chloride 
through the column as indicated above. 
Material from peaks I and II were concentrated and 
analyzed. The unique protein identified by immuno- 
electrophoresis in peak II (Bg.2a) was alpha*-SH 
glycoprotein, and after concentration of the volume, 
unidentified traces of a betar and an alpha, appeared. 
In peak I, alpha* -Zn glycoprotein, a prealbumin, two 
alpha2 glycoproteins and traces of alpha*-SH were 
identified. By radial immunodiffusion of the two 
protein fractions (peak I and II) the recovery of 
Fig.2 (b) 
alpha*-SH was shown to be about 85% in peak II. 
By PAGE-SDS of the latter, a prominent band of 
app. mol. wt 50 000-55 000 was obtained. In a 
second experiment, a protein fraction which contained 
partially denatured alpha*-SH, alphaz-Zn, some uniden 
tidied alpha* and beta globulins, and alpha* macro- 
globulin, was applied to the column. An alphazSH 
fragment, as shown by immunodiffusion and a small 
proportion of native alphaz-SH, were not retained, at 
pH 8.0 (fig.2b, 3). Alpha* macroglubulin coeluted, 
at pH 6.6, with apparently intact alphaz-SH (Bg.2b, 2). 
Sephadex G-200 filtration of this fraction showed two 
peaks: in the first one, alpha2 macroglobulin was 
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eluted in the void volume of the column. Alpha*-SH 
was obtained into the second peak (fig.2b, 45) with 
PAGE-SDS of this fraction showing a major band of 
app. mol. wt 50 000-55 000. 
The chelate column was reactivated and used eight 
times. Under the following conditions (column 
23 X 1.5 cm), more than 60 mg protein were 
chromatographed with identical elution profile and 
when the column was used in the absence of zinc ions, 
all proteins eluted, at pH 8.0, in the starting buffer. 
This chromatographic procedure was highly repro- 
ducible. Thus, under the present experimental condi- 
tions, alpha*-SH was the most strongly absorbed 
protein, at pH 8.0, along with some alphaz-M, alphar -B, 
and traces of unidentified alpha, and beta glyco- 
proteins. On the other hand, alpha*-Zn and some 
other alphaa glycoproteins were never absorbed onto 
the column. As noticed by Porath et al. [.5], imidazole 
and thiol groups may interact with Zn*’ ions fixed on 
the column but it is speculative to draw a parallel 
between the histidine and cysteine (or other amino 
acids) content of these proteins and their binding 
capacity, before their quaternary structure is eluci- 
dated. 
The use of zinc-chelate chromatography may make 
easier the purification of alpha2 -SH which is frequently 
present in alpha*-kininogen preparations [6]. So far, 
the primary structure of alpha*-SH is unknown, and 
further information is needed about its susceptibility 
to cleavage. Furthermore, its biological function is 
not established although Van Oss et al. [7] observed 
that alphaa-SH possessed opsonic properties. Dickson 
et al. [8] showed that this protein was a constituent 
of both adult and foetal human bone matrix. Also, 
the concentration of alphaz-SH is decreased in the 
serum of trauma patients [9] . This observation, added 
to my preliminary results, that the concentration of 
the protein is significantly lowered in sera of patients 
suffering from inflammatory processes (in inverse 
ratio to the increase of ‘acute phase’ proteins) empha- 
sizes the need of further investigation of this plasma 
protein. 
Acknowledgements 
I wish to thank MS Martine Hiron for her expert 
technical assistance and Mr Marc Fontaine for helpful 
discussion. This work was supported by the University 
of Rouen. 
References 
111 
VI 
[31 
[41 
[51 
161 
[71 
PI 
[91 
Heremans, J. (1960) in: Les Globulines seriques du 
systeme Gamma (Arscia S. A., ed) p. 103, Bruxelles 
Schmid, K. and Biirgi, W. (1961) Biochim. Biophys. 
Acta 41,440-453. 
Biirgi, W. and Schmid, K. (1961) J. Biol. Chem. 236, 
1066-1074. 
Schultze, H. E., Heide, K. and Haupt, H. (1962) Natur- 
wiss. 49, 15. 
Porath, J., Carlsson, J., Olsson, I. and Belfrage, G. 
(1975) Nature 258,598-599. 
Londesborough, J. C. and Hamberg, U. (1975) Biochem. 
J. 145,401-403. 
Van Oss, C. J., Gillman, C. F., Bronson, P. M. and 
Border, J. R. (1974) Immun. Commun. 4,329-335. 
Dickson, I. R., Poole, A. R. and Veis, A. (1975) Nature 
256,430-432. 
Van Oss, C. J., Bronson, P. M. and Border, J. R. (1975) 
J. Trauma 15,451-455. 
354 
